Joseph Cappello, VP, Pharmaceutical Development at GENELUX Corp (GNLX), sold 6,300 shares at $2.34 ($15K) on 2024-12-16, disclosed to the SEC on 2024-12-18.
Open-market sale of $15k GNLX by VP, Pharmaceutical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GNLX | SELL | 2026-05-12 | $2K | — | Filing → |
| GNLX | SELL | 2026-03-26 | $2K | — | Filing → |
| GNLX | SELL | 2025-12-11 | $14K | — | Filing → |